Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-18-029411
Filing Date
2018-06-21
Accepted
2018-06-21 06:07:21
Documents
51
Period of Report
2018-06-21

Document Format Files

Seq Description Document Type Size
1 6-K form6k.htm 6-K 11943
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 396476
  Complete submission text file 0001140361-18-029411.txt   2335904

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT bysi-20180331.xml EX-101.INS 328030
4 XBRL TAXONOMY EXTENSION SCHEMA bysi-20180331.xsd EX-101.SCH 37361
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bysi-20180331_cal.xml EX-101.CAL 32415
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bysi-20180331_def.xml EX-101.DEF 220631
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bysi-20180331_lab.xml EX-101.LAB 180819
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bysi-20180331_pre.xml EX-101.PRE 238737
Mailing Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005
Business Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 463009483 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38024 | Film No.: 18910837
SIC: 2834 Pharmaceutical Preparations